Stay updated on Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4. This is a minor versioning update and does not affect study content or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-01-16T01:39:28.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3; the previous Revision: v3.3.2 and the HHS Vulnerability Disclosure link have been removed.
    Difference
    0.1%
    Check dated 2025-12-18T21:51:50.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2, replacing the previous Revision: v3.2.0. No study details or content appeared to be altered.
    Difference
    0.1%
    Check dated 2025-11-27T04:09:44.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Removed a site-wide government-funding notice; core study details and eligibility criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-19T21:44:48.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    No additions or deletions to key study information were observed; only minor layout and visual adjustments are apparent. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-10-29T02:32:48.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    Introducing a government-funded operation notice and a new software version (v3.2.0), replacing the previous version (v3.1.0).
    Difference
    4%
    Check dated 2025-10-06T06:37:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial page.